(Q38449856)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15161084%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

A single dose of killed Mycobacterium bovis BCG in a novel class of adjuvant (Novasome) protects guinea pigs from lethal tuberculosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15161084%20AND%20SRC:MED&resulttype=core&format=json

Mycobacterium tuberculosis

28 December 2019

main subject

1 reference

Mycobacterium bovis

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15161084%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

D Craig Wright

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15161084%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Joan Brisker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15161084%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Ann Williams

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15161084%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Graham Hatch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15161084%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Dolores Gavier-Widén

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15161084%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Graham Hall

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15161084%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Philip D Marsh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15161084%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

R Glyn Hewinson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15161084%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

language of work or name

English

0 references

publication date

1 February 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15161084%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15161084%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15161084%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15161084%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

1063-1071

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15161084%20AND%20SRC:MED&resulttype=core&format=json

Identification of Mycobacterium tuberculosis DNA in a pre-Columbian Peruvian mummy

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Identification of Mycobacterium DNA in an Egyptian Pott's disease of 5400 years old

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

The epidemiology of Mycobacterium bovis infections in animals and man: A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Tuberculosis vaccine development: recent progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

The immunogenicity of single and combination DNA vaccines against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

New tuberculosis vaccines based on attenuated strains of the Mycobacterium tuberculosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Priming of memory but not effector CD8 T cells by a killed bacterial vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Protection by killed vole bacillus vaccine against experimental tuberculosis in guinea pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Resistance to intravenous inoculation of Mycobacterium tuberculosis H37Rv in mice of different inbred strains following immunization with a leprosy vaccine based on Mycobacterium w.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Vaccination against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Antituberculous immunity in mice vaccinated with killed tubercle bacilli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Evaluation of an immunohistochemical test with polyclonal antibodies raised against mycobacteria used in formalin-fixed tissue compared with mycobacterial specific culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Cross-clade p17 peptide recognition by antisera to HGP-30, a 30-amino acid synthetic peptide antigen from HIV type 1 p17.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Genetic systems for mycobacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Experimental Legionnaires' disease in SCID-Beige mice reconstituted with human leucocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

A guinea pig model of low-dose Mycobacterium bovis aerogenic infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Liposomes containing lipid A as a potent non-toxic adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

ESAT-6 subunit vaccination against Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

A comparative study of live and killed vaccines in experimental tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Immunization of mice with ultraviolet killed tuberculosis vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Evidence for an alpha/beta T cell-independent mechanism of resistance to mycobacteria. Bacillus-Calmette-Guerin causes progressive infection in severe combined immunodeficient mice, but not in nude mice or in mice depleted of CD4+ and CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Potency testing of BCG vaccines on white mice: influence of variables on survival time, lung findings and vaccine assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

The physiology and pathogenicity of Mycobacterium tuberculosis grown under controlled conditions in a defined medium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Cultivation of Mycobacterium bovis BCG in bioreactors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Proteins released from Mycobacterium tuberculosis during growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2003.05.002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15161084%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference